Evidence map›Paper›PMID 42368453›Full record

ArticleFrontiers in cell and developmental biology2026

A structure-aware and causal-invariant framework for glioma cell classification in pathological images.

Taishan Chen, Ying Zhang, Cai Jing, Yao Liu, Tanjun Wei, Shujun Xia, Xianhai Li

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Taishan Chen *Department of Neurosurgery, Dazhou Central Hospital, Dazhou, China.
Ying Zhang *Department of Neurosurgery, Dazhou Central Hospital, Dazhou, China.
Cai JingDepartment of Neurosurgery, Dazhou Central Hospital, Dazhou, China.
Yao LiuDepartment of Pharmacy, Dazhou Integrated TCM & Western Medical Hospital, Dazhou, China.
Tanjun WeiDepartment of Pharmacy, Dazhou Integrated TCM & Western Medical Hospital, Dazhou, China.
Shujun XiaDepartment of Pharmacy, Dazhou Integrated TCM & Western Medical Hospital, Dazhou, China.
Xianhai LiDepartment of Pharmacy, Dazhou Integrated TCM & Western Medical Hospital, Dazhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Accurate classification of glioma cells and normal cells remains challenging due to insufficient fine-grained pathological feature representation, limited modeling of morphological relationships, and interference from staining variation, background noise, and imaging bias. Methods: This study proposes a hybrid classification framework that integrates a convolutional residual local detail enhancement front-end, a Transformer backbone, a morphological relation modeling mechanism, and a causal-invariant discrimination module. The framework enhances nuclear boundaries, staining textures, and local heterogeneity, models cross-regional contextual and morphological correlations, and suppresses non-essential disturbance factors. Results: Experiments on a dataset of 473 subjects and 859 pathological images show that the proposed method achieves 98.46% accuracy, 97.94% precision, 98.07% recall, and 0.987 AUC, outperforming competing methods. Ablation and visualization results further confirm the effectiveness of the key modules. Discussion: The proposed method improves fine-grained feature representation, structural relation modeling, and classification robustness, providing reliable technical support for intelligent glioma-related pathological cell recognition.

Indexed as

causal-invariant discriminationglioma cell classificationmorphological relation modelingpathological image analysistransformer

Identifiers

PMID42368453
PMCPMC13303599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.